# Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

> **NCT00259077** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 270 (—)

## Conditions studied

- Non-erosive Reflux Disease

## Interventions

- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT00259077
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2004-07
- **Final completion:** 2004-07
- **Target enrollment:** 270 (—)
- **Last updated:** 2011-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259077, "Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00259077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*